ProQR Therapeutics (PRQR) Total Current Liabilities (2013 - 2026)
ProQR Therapeutics' Total Current Liabilities was $40.54 million in the quarter ended Jun 30, 2026, up 8.2% from $37.45 million a year earlier but down 1.2% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Total Current Liabilities (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Current Liabilities at ProQR Therapeutics came in at $36.65 million, down 13.0% from the prior year.
- Total Current Liabilities shows a five-year compound annual growth rate of 25.5% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Current Liabilities was $42.11 million in the year ended Dec 31, 2024 (+13.8%), $37 million in the year ended Dec 31, 2023 (+67.3%), $22.12 million in the year ended Dec 31, 2022 (-32.3%) and $32.66 million in the year ended Dec 31, 2021 (+177.7%).
- Quarterly Total Current Liabilities has moved between $18.42 million (the quarter ended Mar 31, 2023) and $43.53 million (the quarter ended Sep 30, 2024) over five years.
- Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with growth averaging 6.9%.
- The best year-over-year quarter for Total Current Liabilities over five years was the quarter ended Sep 30, 2021 (growth of 223.8%); the worst was the quarter ended Sep 30, 2022 (a decline of 33.5%).
- Per Business Quant data, PRQR's Total Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $41.04 million (quarter ended Mar 31, 2026), $37.76 million (quarter ended Dec 31, 2025) and $38.74 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | ProQR Therapeutics | 173.85 Mn | -289.75 Mn | - | 40.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.54 Mn |
| Mar 31, 2026 | 41.04 Mn |
| Dec 31, 2025 | 37.76 Mn |
| Sep 30, 2025 | 38.74 Mn |
| Jun 30, 2025 | 37.45 Mn |
| Mar 31, 2025 | 35.47 Mn |
| Dec 31, 2024 | 41.57 Mn |
| Sep 30, 2024 | 43.53 Mn |
| Jun 30, 2024 | 40.15 Mn |
| Mar 31, 2024 | 37.39 Mn |
| Dec 31, 2023 | 36.80 Mn |
| Sep 30, 2023 | 29.01 Mn |
| Jun 30, 2023 | 25.02 Mn |
| Mar 31, 2023 | 18.42 Mn |
| Dec 31, 2022 | 21.41 Mn |
| Sep 30, 2022 | 27.20 Mn |
| Jun 30, 2022 | 28.96 Mn |
| Mar 31, 2022 | 26.62 Mn |
| Dec 31, 2021 | 31.57 Mn |
| Sep 30, 2021 | 40.91 Mn |
API Access
ProQR Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();